At Avacta we have developed Affimer^® technology, an engineered alternative to antibodies. Based on a small protein, Affimer technology can be quickly developed to bind with high specificity and affinity to a wide range of targets.

Affimer proteins can be developed as therapeutic molecules and can be used in a wide range of other life sciences applications in research and diagnostics.

For further information see our website www.avacta.com

Address:
Unit 20 Ash Way
Thorp Arch Estate
Wetherby
LS23 7FA

Phone: 01904217070

Website: Avacta Life Sciences